Previous 10 | Next 10 |
-- Fiscal 2020 Revenues of $90.1M; Increase of 66% over $54.4M in Fiscal 2019 -- -- Strong Growth in Synthetic Biology, NGS Businesses -- -- Twist Biopharma Established 13 Partnerships, 8 with Milestones and/or Royalties in FY20 -- -- Expect Revenue of $110M to $118M for Fis...
Twist Bioscience Corporation (Nasdaq: TWST) today announced preclinical data for three of its proprietary antibodies against the S1 protein in SARS-CoV-2, the virus that causes COVID-19. The data show that TB202-3 and TB202-63, both single domain VHH “nanobodies,” protect ...
Twist Bioscience (NASDAQ:TWST) is scheduled to announce Q4 earnings results on Monday, November 23rd, before market open.The consensus EPS Estimate is -$0.71 (+26.0% Y/Y) and the consensus Revenue Estimate is $22.66M (+44.0% Y/Y). For further details see: Twist Bioscience Q4 2020 Earnin...
[[BZUN]], [[KFY]], [[TWST]], [[WMG]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
Twist Bioscience (TWST) and Biotia announce the availability of an important new research tool for the sequencing and surveillance of COVID-19.The companies have developed the SARS-CoV-2 Next-Generation Sequencing ((NGS)) Assay for research-use only ((RUO)).The SARS-CoV-2 NGS Assay ident...
-- Data from Research Use Only Assay and Software Presented at Infectious Disease Week 2020 -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a ...
Twist Bioscience Corporation (NASDAQ: TWST), today announced that it ranked 60 th on Deloitte’s Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 26...
-- Panel Distinguishes Between More than 3,000 Different infectious Diseases -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availabilit...
-- Partners with Ginkgo Bioworks on “Ginkgo Challenge” -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced its continued partnership w...
Twist Bioscience ([[TWST]] +3.6%), Illumina ([[ILMN]] -0.5%) and Western Digital ([[WDC]] -3.6%) will team up with Microsoft to advance the field of data storage in DNA.The companies, along with member organizations, will collaborate to create a comprehensive roadmap aimed at helping the indu...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...